Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
ConditionPeyronie Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-65
SponsorUskudar University
About this trial
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
Eligibility criteria
Qualifiers
Male individuals aged 18-65 years.
Having been diagnosed with Peyronie's Disease that has been stable (without increasing pain and curvature) for at least 6 months.
Presence of palpable penile plaque.
Disqualifiers
Acute inflammatory stage (painful, progressive)
Having previously undergone surgery, needle therapy (e.g., Xiaflex), or Extracorporeal Shockwave Therapy for peyronie's disease.
Uncontrolled diabetes, severe coagulopathy, or receiving anticoagulant therapy.
History of penile cancer.
Trial design
Treatments tested in this trial
- Extracorporeal Shockwave Therapy
- control
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov